Exercise-triggered mitral leak repair study
Treatments studied
Part of Heart & circulation clinical trials.
This trial tests a minimally invasive procedure to repair a leaky mitral valve that only becomes severe during exercise. If you have mild to moderate leakage at rest that gets worse when you are active, this study may help determine if the repair improves your symptoms and heart function.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have mild to moderate mitral valve leakage at rest that becomes severe when you exercise.
- You have symptoms like shortness of breath or fatigue (NYHA class II to IV).
- You have had a hospitalization for heart failure in the past year or have elevated NT-proBNP levels.
- You have been on stable heart failure medications for at least 30 days.
- You are at least 18 years old and can give informed consent.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a procedure called transcatheter edge-to-edge repair (TEER) for people with a specific type of heart valve leak (functional mitral regurgitation) that is causing heart failure symptoms. The procedure is less invasive than open-heart surgery and aims to improve symptoms and quality of life.
This study tests a procedure to fix a leaky heart valve (mitral valve) in people with heart failure, with the goal of helping them tolerate and benefit from standard heart failure medicines. It asks whether adding this valve repair to optimized medicines is better than medicines alone.
This trial tests a new device designed to fix a leaky mitral valve in people with heart failure. It may help you breathe easier and feel less tired if your valve leak is severe and medicines have not been enough.
This trial tests a less invasive procedure (edge-to-edge mitral valve repair) for people with ATTR-CM and a leaky mitral valve. It aims to see if this repair can help improve symptoms compared to standard medical therapy alone.
This trial tests a new device called the Capstan system to fix a leaky mitral valve (mitral regurgitation) without open-heart surgery. It may help people whose valve leak is moderate to severe and still have symptoms despite medicines.
This trial studies an “epicardial” device placed during planned heart surgery to reduce mitral valve leaking (“mitral regurgitation”). If you have moderate-to-severe valve leak from ischemic heart disease and are already scheduled for heart surgery, this may help improve how well the valve works.
Hear when a new Heart Failure - NYHA II - IV trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.